Allspring Global Investments Holdings, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$8.16 - $15.1 $13,056 - $24,160	-1,600 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$11.2 - $16.97 $481 - $729	-43 Reduced 2.62%	1,600 $23,000
Q4 2021 Jan 28, 2022	BUY	$12.36 - $18.28 $20,307 - $30,034	1,643 New	1,643 $21,000

Others Institutions Holding KALV

# of Institutions

125

Shares Held

47.8M

Call Options Held

551K

Put Options Held

110K

Vr Adviser, LLC New York, NY

6.25M
Shares

$56 Million
7.5% of portfolio
Tang Capital Management LLC San Diego, CA

4.32M
Shares

$38.7 Million
4.26% of portfolio
Suvretta Capital Management, LLC New York, NY

4.21M
Shares

$37.7 Million
1.92% of portfolio
Vestal Point Capital, LP New York, NY

4M
Shares

$35.8 Million
3.51% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.69M
Shares

$33 Million
2.3% of portfolio

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account